Unilever CEO warns of ‘substantial price increases’ confirms GSK deal is off the table – CNBC

Unilever has ruled out any “transformational” acquisitions for the foreseeable future after its failed bid for GlaxoSmithKline’s consumer arm drew heavy investor criticism and sent its share price tu… [read more]

Leave a Reply

Your email address will not be published.